|
Michael R. Henson, has founded or served as CEO and chairman/Board member for sixteen emerging healthcare (medical device or biotechnology) firms. Six of these were privately held firms acquired by multinational companies, while five have advanced through the initial public offering (IPO) stage. Several of these companies remain closely held private firms. In total, these firms have received financial investments of approximately $1 billion and have employed in excess of 1,000 people. In addition, Mr. Henson is a member of the Board of Directors of the Cardiovascular Research Foundation (CRF), one of the largest clinical cardiovascular research foundations in the United States. Mr. Henson also serves as principal Manager for four private investment funds and as an advisor to two additional private investment funds all focused on early and mid - stage medical device startup ventures. | 